TEHRAN (Iran News) – The CEO of the Iranian Blood Transfusion Organization (IBTO) said that Iran is ranked as the second country for conducting the Convalescent Plasma Therapy plan after China and followed by the US.
Payman Eshqi made the announcement while reporting on the IBTO performance in the field of collecting plasma from patients with COVID-19 who were fully recovered in order to use them to produce drugs for patients who are currently in critical conditions, Mehr News Agency (MNA) reported.
“Iran had been the second country after china who started to conduct Convalescent plasma Therapy plan,” Eshqi said.
He went on to say that the COVI-19 patients who are recovered from the disease should consider that as time goes on the antibody in their blood will be decreased. The golden time for plasma donation is one or two months after complete recovery, he stressed.
IBTO is the only legal body in Iran in charge of providing blood products for patients.
- source : Iran Daily, Irannews